vTv Therapeutics (NASDAQ:VTVT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance Shares of vTv Therapeutics stock opened at $14.87 on Monday. The stock has a market cap of $38.81 […]
More Stories
Special Counsel Jack Smith Drops Trump Election Case, Classified Documents Appeal
By Jack Phillips Special counsel Jack Smith on Monday dropped his election interference case against President-elect Donald Trump, while also...
iShares Core S&P 500 ETF (NYSEARCA:IVV) Sets New 12-Month High – Should You Buy?
iShares Core S&P 500 ETF (NYSEARCA:IVV – Get Free Report)’s share price reached a new 52-week high during trading on...
Oceaneering International (NYSE:OII) Sets New 1-Year High – Time to Buy?
Shares of Oceaneering International, Inc. (NYSE:OII – Get Free Report) reached a new 52-week high during trading on Monday ....
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Acorn Wealth Advisors LLC
Acorn Wealth Advisors LLC boosted its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 27.6%...
iShares ESG Aware MSCI USA ETF (NASDAQ:ESGU) Hits New 52-Week High – What’s Next?
iShares ESG Aware MSCI USA ETF (NASDAQ:ESGU – Get Free Report) reached a new 52-week high during mid-day trading on...
argenx (NASDAQ:ARGX) Reaches New 52-Week High – Still a Buy?
argenx SE (NASDAQ:ARGX – Get Free Report)’s stock price reached a new 52-week high on Monday . The company traded...